{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:43:20Z","timestamp":1778291000419,"version":"3.51.4"},"reference-count":34,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2015.0605","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:24:09Z","timestamp":1525253049000},"source":"Crossref","is-referenced-by-count":7,"title":["Detecting Prostate Cancer"],"prefix":"10.3238","author":[{"given":"Marko","family":"Brock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian von","family":"Bodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcri","family":"Palisaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Martin-Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Noldus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"key":"10.3238\/arztebl.2015.0605_ref1","doi-asserted-by":"crossref","unstructured":"Heidenreich A, Aus G, Bolla M, et al.: EAU guidelines on prostate cancer. European urology 2008; 53: 68\u201380","DOI":"10.1016\/j.eururo.2007.09.002"},{"key":"10.3238\/arztebl.2015.0605_ref2","doi-asserted-by":"crossref","unstructured":"Gosselaar C, Roobol MJ, Roemeling S, Wolters T, van Leenders GJ, Schroder FH: The value of an additional hypoechoic lesion-directed biopsy core for detecting prostate cancer. BJU international 2008; 101: 685\u201390","DOI":"10.1111\/j.1464-410X.2007.07309.x"},{"key":"10.3238\/arztebl.2015.0605_ref3","doi-asserted-by":"crossref","unstructured":"Nevoux P, Ouzzane A, Ahmed HU, et al.: Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series. BJU international 2012; 110: 517\u201323","DOI":"10.1111\/j.1464-410X.2011.10776.x"},{"key":"10.3238\/arztebl.2015.0605_ref4","doi-asserted-by":"crossref","unstructured":"Haas GP, Delongchamps NB, Jones RF, et al.: Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 2007; 99: 1484\u20139","DOI":"10.1093\/jnci\/djm153"},{"key":"10.3238\/arztebl.2015.0605_ref5","doi-asserted-by":"crossref","unstructured":"Walz J, Graefen M, Chun FK, et al.: High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. European urology 2006; 50: 498\u2013505","DOI":"10.1016\/j.eururo.2006.03.026"},{"key":"10.3238\/arztebl.2015.0605_ref6","doi-asserted-by":"crossref","unstructured":"Welch HG, Fisher ES, Gottlieb DJ, Barry MJ: Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst 2007; 99: 1395\u2013400","DOI":"10.1093\/jnci\/djm119"},{"key":"10.3238\/arztebl.2015.0605_ref7","doi-asserted-by":"crossref","unstructured":"Abdollah F, Scattoni V, Raber M, et al.: The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU international 2011; 108: 366\u201371","DOI":"10.1111\/j.1464-410X.2010.09876.x"},{"key":"10.3238\/arztebl.2015.0605_ref8","doi-asserted-by":"crossref","unstructured":"Ahmed HU, Emberton M, Kepner G, Kepner J: A biomedical engineering approach to mitigate the errors of prostate biopsy. Nature reviews Urology 2012; 9: 227\u201331","DOI":"10.1038\/nrurol.2012.3"},{"key":"10.3238\/arztebl.2015.0605_ref9","doi-asserted-by":"crossref","unstructured":"Carlson GD, Calvanese CB, Kahane H, Epstein JI: Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variability. Urology 1998; 51: 525\u20139","DOI":"10.1016\/S0090-4295(98)00002-8"},{"key":"10.3238\/arztebl.2015.0605_ref10","doi-asserted-by":"crossref","unstructured":"Fernandes ET, Sundaram CP, Long R, Soltani M, Ercole CJ: Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer? British journal of urology 1997; 79: 615\u20137 CrossRef","DOI":"10.1046\/j.1464-410X.1997.00126.x"},{"key":"10.3238\/arztebl.2015.0605_ref11","doi-asserted-by":"crossref","unstructured":"Chun FK, Steuber T, Erbersdobler A, et al.: Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. European urology 2006; 49: 820\u20136","DOI":"10.1016\/j.eururo.2005.11.007"},{"key":"10.3238\/arztebl.2015.0605_ref12","doi-asserted-by":"crossref","unstructured":"Song JM, Kim CB, Chung HC, Kane RL: Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men. Yonsei medical journal 2005; 46: 414\u201324","DOI":"10.3349\/ymj.2005.46.3.414"},{"key":"10.3238\/arztebl.2015.0605_ref13","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF): Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Fr\u00fcherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Langversion 3.1, 2014 AWMF Registernummer: 034\/022OL, (Last accessed on: 3 June 2015)."},{"key":"10.3238\/arztebl.2015.0605_ref14","doi-asserted-by":"crossref","unstructured":"Sciarra A, Barentsz J, Bjartell A, et al.: Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. European urology 2011; 59: 962\u201377","DOI":"10.1016\/j.eururo.2011.02.034"},{"key":"10.3238\/arztebl.2015.0605_ref15","doi-asserted-by":"crossref","unstructured":"Sonn GA, Margolis DJ, Marks LS: Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. Urologic oncology 2014; 32: 903\u201311","DOI":"10.1016\/j.urolonc.2013.08.006"},{"key":"10.3238\/arztebl.2015.0605_ref16","doi-asserted-by":"crossref","unstructured":"Epstein JI, Walsh PC, Carmichael M, Brendler CB: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368\u201374","DOI":"10.1001\/jama.271.5.368"},{"key":"10.3238\/arztebl.2015.0605_ref17","doi-asserted-by":"crossref","unstructured":"Moore CM, Kasivisvanathan V, Eggener S, et al.: Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. European urology 2013; 64: 544\u201352","DOI":"10.1016\/j.eururo.2013.03.030"},{"key":"10.3238\/arztebl.2015.0605_ref18","doi-asserted-by":"crossref","unstructured":"Roehl KA, Antenor JA, Catalona WJ: Serial biopsy results in prostate cancer screening study. The Journal of urology 2002; 167: 2435\u20139","DOI":"10.1016\/S0022-5347(05)64999-3"},{"key":"10.3238\/arztebl.2015.0605_ref19","doi-asserted-by":"crossref","unstructured":"Sonn GA, Chang E, Natarajan S, et al.: Value of Targeted Prostate Biopsy Using Magnetic Resonance-Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen. European urology 2013","DOI":"10.1016\/j.eururo.2013.03.025"},{"key":"10.3238\/arztebl.2015.0605_ref20","doi-asserted-by":"crossref","unstructured":"Vourganti S, Rastinehad A, Yerram NK, et al.: Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. The Journal of urology 2012; 188: 2152\u20137","DOI":"10.1016\/j.juro.2012.08.025"},{"key":"10.3238\/arztebl.2015.0605_ref21","doi-asserted-by":"crossref","unstructured":"Zaytoun OM, Moussa AS, Gao T, Fareed K, Jones JS: Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population. The Journal of urology 2011; 186: 850\u20134","DOI":"10.1016\/j.juro.2011.04.069"},{"key":"10.3238\/arztebl.2015.0605_ref22","unstructured":"Turk Z, Hollberg H, Dill T, Kaspers I, Isbarn H: [Prostate cancer detection rates : Comparison of standard biopsy with prompt rebiopsy and a one-time extended biopsy.]. Der Urologe Ausg 2014."},{"key":"10.3238\/arztebl.2015.0605_ref23","doi-asserted-by":"crossref","unstructured":"Loeb S, van den Heuvel S, Zhu X, Bangma CH, Schroder FH, Roobol MJ: Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. European urology 2012; 61: 1110\u20134","DOI":"10.1016\/j.eururo.2011.12.058"},{"key":"10.3238\/arztebl.2015.0605_ref24","doi-asserted-by":"crossref","unstructured":"Pepe P, Aragona F: Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 2013; 81: 1142\u20136","DOI":"10.1016\/j.urology.2013.02.019"},{"key":"10.3238\/arztebl.2015.0605_ref25","doi-asserted-by":"crossref","unstructured":"Valerio M, Donaldson I, Emberton M, et al.: Detection of clinically significant prostate cancer using magnetic resonance imagi g-ultrasound fusion targeted biopsy: a systematic review. European urology 2014.","DOI":"10.1016\/j.eururo.2014.10.026"},{"key":"10.3238\/arztebl.2015.0605_ref26","doi-asserted-by":"crossref","unstructured":"Kuru TH, Roethke MC, Seidenader J, et al.: Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. The Journal of urology 2013; 190: 1380\u20136","DOI":"10.1016\/j.juro.2013.04.043"},{"key":"10.3238\/arztebl.2015.0605_ref27","doi-asserted-by":"crossref","unstructured":"Turkbey B, Mani H, Shah V, et al.: Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. The Journal of urology 2011; 186: 1818\u201324","DOI":"10.1016\/j.juro.2011.07.013"},{"key":"10.3238\/arztebl.2015.0605_ref28","doi-asserted-by":"crossref","unstructured":"Brock M, Roghmann F, Sonntag C, et al.: Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy. Ultraschall Med 2014; [Epub ahead of print","DOI":"10.1055\/s-0034-1366563"},{"key":"10.3238\/arztebl.2015.0605_ref29","doi-asserted-by":"crossref","unstructured":"Brock M, von Bodman C, Sommerer F, et al.: Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy. BJU international 2011; 108: E217\u201322","DOI":"10.1111\/j.1464-410X.2011.10209.x"},{"key":"10.3238\/arztebl.2015.0605_ref30","doi-asserted-by":"crossref","unstructured":"Salomon G, Kollerman J, Thederan I, et al.: Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. European urology 2008; 54: 1354\u201362","DOI":"10.1016\/j.eururo.2008.02.035"},{"key":"10.3238\/arztebl.2015.0605_ref31","doi-asserted-by":"crossref","unstructured":"Halpern EJ, McCue PA, Aksnes AK, Hagen EK, Frauscher F, Gomella LG: Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology 2002; 222: 361\u20136 CrossRef","DOI":"10.1148\/radiol.2222010582"},{"key":"10.3238\/arztebl.2015.0605_ref32","doi-asserted-by":"crossref","unstructured":"Walz J, Thomassin-Piana J, Poizat F: External validation of the anna\/c-trus system regarding the correct identification of prostate cancer lesions in the diagnosis of prostate cancer. The Journal of urology 2012; 187(Suppl): 820","DOI":"10.1016\/j.juro.2012.02.2197"},{"key":"10.3238\/arztebl.2015.0605_ref33","doi-asserted-by":"crossref","unstructured":"Simmons LA, Autier P, Zat\u2019ura F, et al.: Detection, localisation and characterisation of prostate cancer by prostate HistoScanning. BJU international 2012; 110: 28\u201335","DOI":"10.1111\/j.1464-410X.2011.10734.x"},{"key":"10.3238\/arztebl.2015.0605_ref34","doi-asserted-by":"crossref","unstructured":"Barentsz JO, Richenberg J, Clements R, et al.: ESUR prostate MR guidelines 2012. European radiology 2012; 22: 746\u201357","DOI":"10.1007\/s00330-011-2377-y"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:59:30Z","timestamp":1638799170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2015.0605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2015.0605","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]}}}